Reactivation of infectious simian virus 40 from normal human tissues

References

• Agostini H T, Yanagihara R, Davis V, Ryschkewitsch C F, Stoner G L. 1997; Asian genotypes of JC virus in Native Americans and in a Pacific Island population: markers of viral evolution and human migration, Proc Natl Acad Sci U S A. 94: 14542–14546
   Google Scholar
• Barbanti-Brodano G, Martini F, De, Mattei M, Lazzarin L, Corallini A, Tognon M. 1998; BK and JC human polyomaviruses and simian virus 40: natural history of infection in humans, experimental oncogenicity and association with human tumors, Adv Virus Res. 50: 69–99
   Google Scholar
• Barbanti-Brodano G, Sabbioni S, Martini F, Corallini A, Tognon M. 2004; Simian Virus 40 infection in humans and association with human diseases: results and hypotheses, Virology. 318: 1–8
   Google Scholar
• Basetse H R, Lecatsas G, Gerber L J. 2002; An investigation of the occurrence of SV40 antibodies in South Africa, S Afr Med J. 92: 825–828
   Google Scholar
• Bright R K, Kimchi E T, Shearer M H, Kennedy R C, Pass H I. 2002; SV40 Tag-specific cytotoxic T lymphocytes generated from the peripheral blood of malignant pleural mesothelioma patients, Cancer Immunol Immunother. 50: 682–690
   Google Scholar
• Butel J S, Lednicky J A. 1999; Cell and molecular biology of simian virus 40: implications for human infections and disease, J Natl Cancer Inst. 91: 119–134
   Google Scholar
• Dolcetti R, Martini F, Quaia M, Gloghini A, Vignocchi B, Cariati R, Martinelli M, Carbone A, Boiocchi M, Tognon M. 2003; Simian virus 40 sequences in human lymphoblastoid B-cell lines, J Virol. 77: 1595–1597
   Google Scholar
• Ferber D. 2002; Public health. Creeping consensus on SV40 and polio vaccine, Science. 298: 725–727
   Google Scholar
• Garcea R L, Imperiale M J. 2003; Simian virus 40 infection of humans, J Virol. 77: 5039–5045
   Google Scholar
• Geissler E, Konzer P, Scherneck S, Zimmerman W. 1985; Sera collected before introduction of contaminated polio vaccine contain antibodies against SV40, Acta Virol. 29: 420–423
   Google Scholar
• Huang K C, Yamasaki E F, Snapka R M. 1999; Maintenance of episomal SV40 genomes in GM637 human fibroblasts, Virology. 262: 457–469
   Google Scholar
• Jafar S, Rodriguez-Barradas M, Graham D Y, Butel J S. 1998; Serological evidence of SV40 infections in HIV-infected and HIV-negative adults, J Med Virol. 54: 276–284
   Google Scholar
• Jasani B, Cristaudo A, Emri S A, Gazdar A F, Gibbs A, Krynska B, Miller C, Mutti L, Radu C, Tognon M, Procopio A. 2001; Association of SV40 with human tumors, Semin Cancer Biol. 11: 49–61
   Google Scholar
• Lednicky J A, Garcea R L, Bergsagel D J, Butel J S. 1995; Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors, Virology. 212: 710–717
   Google Scholar
• Lednicky J A, Butel J S. 1997; A coupled PCR and restriction digest method for the detection and analysis of the SV40 regulatory region in infected-cell lysates and clinical samples, J Virol Methods. 64: 1–9
   Google Scholar
• Li R M, Branton M H, Tanawattanacharoen S, Falk R A, Jennette J C, Kopp J B. 2002a; Molecular identification of SV40 infection in human subjects and possible association with kidney disease, J Am Soc Nephrol. 13: 2320–2330
   Google Scholar
• Li R M, Mannon R B, Kleiner D, Tsokos M, Bynum M, Kirk A D, Kopp J B. 2002b; BK virus and SV40 co-infection in polyomavirus nephropathy, Transplantation. 74: 1497–1504
   Google Scholar
• Martini F, De, Mattei M, Iaccheri L, Lazzarin L, Barbanti-Brodano G, Gerosa M, Tognon M. 1995; Human brain tumors and simian virus 40, J Natl Cancer Inst. 87: 1331
   Google Scholar
• Martini F, Dolcetti R, Gloghini A, Iaccheri L, Carbone A, Boiocchi M, Tognon M. 1998; Simian-virus-40 footprints in human lymphoproliferative disorders of HIV− and HIV+ patients, Int J Cancer. 78: 669–674
   Google Scholar
• Martini F, Iaccheri L, Lazzarin L, Corallini A, Gerosa M, Iuzzolino P, Barbanti-Brodano G, Tognon M. 1996; Simian virus 40 early region and large T antigen in human brain tumors, peripheral blood cells and sperm fluids from healthy individuals, Cancer Res. 56: 4820–4825
   Google Scholar
• Martini F, Lazzarin L, Iaccheri L, Vignocchi B, Finocchiaro G, Magnani I, Serra M, Scotlandi K, Barbanti-Brodano G, Tognon M. 2002; Different simian virus 40 genomic regions and sequences homologous with SV40 large T antigen in DNA of human brain and bone tumors and of leukocytes from blood donors, Cancer. 94: 1037–1048
   Google Scholar
• Minor P D, Dunn G, Pipkin P A. 2001; Detection and growth kinetics of SV40 preparations with different enhancer element copy number, Vaccine. 19: 3467–3471
   Google Scholar
• Pacini F, Vivaldi A, Santoro M, Fedele M, Fusco A, Romei C, Basolo F, Pinchera A. 1998; Simian virus 40-like DNA sequences in human papillary thyroid carcinomas, Oncogene. 16: 665–659
   Google Scholar
• Rizzo P, Di, Resta I, Powers A, Ratner H, Carbone M. 1999; Unique strains of SV40 in commercial poliovaccines from 1955 not readily identifiable with current testing for SV40 infection, Cancer Res. 59: 6103–6108. [PUBMED], [INFOTRIEVE]
   Google Scholar
• Sangar D, Pipkin P A, Wood D J, Minor P D. 1999; Examination of poliovirus vaccine preparations for SV40 sequences, Biologicals. 27: 1–10
   Google Scholar
• Strickler H D, Rosenberg P S, Devesa S S, Hertel J, Fraumeni J F, Goedert J J. 1998; Contamination of poliovirus vaccines with simian virus 40 (1955–1963) and subsequent cancer rates, JAMA. 279: 292–295. [PUBMED]
   Google Scholar